Atrion Corporation (NASDAQ:ATRI) Issues Quarterly Earnings Results
Atrion Corporation (NASDAQ:ATRI) announced its earnings results on Tuesday. The medical instruments supplier reported $5.40 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. Atrion Corporation had a net margin of 20.91% and a return on equity of 17.61%. The company had revenue of $36.16 million during the quarter.
Atrion Corporation (ATRI) traded up 0.97% during mid-day trading on Wednesday, reaching $642.10. 6,197 shares of the company’s stock traded hands. Atrion Corporation has a one year low of $393.96 and a one year high of $691.95. The firm’s 50-day moving average price is $629.36 and its 200 day moving average price is $532.12. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 38.99 and a beta of 0.91.
In other news, Chairman Emile A. Battat sold 721 shares of Atrion Corporation stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $542.64, for a total value of $391,243.44. Following the transaction, the chairman now directly owns 152,112 shares of the company’s stock, valued at approximately $82,542,055.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Emile A. Battat sold 100 shares of Atrion Corporation stock in a transaction on Friday, June 9th. The shares were sold at an average price of $585.50, for a total transaction of $58,550.00. Following the completion of the transaction, the chairman now directly owns 149,081 shares in the company, valued at $87,286,925.50. The disclosure for this sale can be found here. Insiders sold a total of 3,392 shares of company stock worth $1,900,070 over the last ninety days. Corporate insiders own 24.23% of the company’s stock.
Separately, BidaskClub lowered shares of Atrion Corporation from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 27th.
About Atrion Corporation
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.